Experienced Leadership. Proven Execution.
Galenicap is led by a seasoned team of industry experts with experience across more than 100 drug formulation programs and a strong track record in advancing therapies through Phase I and II clinical development.
Laurens G. Theunis
Executive Director
Daria Alekseeva
SPV & Project Lead
Jan Wit
Product & CMC Development
Hans Platteeuw
Executive Director & Chief Development Officer
Cindy Dieteren
Lead of Translational Sciences & SPV Lead
Hans Van der Steen
CEO, Nomion Medicines
Donald Kalff
Non-Executive Director
%202_edited.jpg)
Bertine Vorstenbosch
Regulatory CMC Lead
James Burt
Board Advisor
Marek Cichocki
SPV & Project Lead
Carolin Schwartner-Lehr
Business Development Lead
Dirk Reyn
Board Advisor
Join us
We are building a team focused on transforming proven science into better therapies and meaningful clinical impact. Our work sits at the intersection of innovation and execution, addressing unmet medical needs through a disciplined and hands-on approach.
At Galenicap, you will be part of a dynamic and collaborative environment where scientific insight, entrepreneurial thinking, and practical execution come together. We are always interested in connecting with individuals who are driven by impact and motivated to contribute to the development of differentiated therapies.
Project Managers (Clinical)
Selected candidates will be responsible for the preparation and implemenation of clinical development programs
Project Manager (Development)
Selected candidates will be responsible for the design and implementation of drug formulation and CMC development projects
Apply now!
We are always looking for great talent. Give us a call or send us your resume! Contact